| pubmed-article:15847900 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15847900 | lifeskim:mentions | umls-concept:C0153567 | lld:lifeskim |
| pubmed-article:15847900 | lifeskim:mentions | umls-concept:C1457887 | lld:lifeskim |
| pubmed-article:15847900 | lifeskim:mentions | umls-concept:C0034380 | lld:lifeskim |
| pubmed-article:15847900 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
| pubmed-article:15847900 | lifeskim:mentions | umls-concept:C0015672 | lld:lifeskim |
| pubmed-article:15847900 | lifeskim:mentions | umls-concept:C0596545 | lld:lifeskim |
| pubmed-article:15847900 | lifeskim:mentions | umls-concept:C2348867 | lld:lifeskim |
| pubmed-article:15847900 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:15847900 | pubmed:dateCreated | 2005-4-25 | lld:pubmed |
| pubmed-article:15847900 | pubmed:abstractText | This paper reports on how patients with uterine cancer, receiving radiotherapy, experience fatigue, other symptoms and global quality of life. The results showed that fatigue increased significantly during the therapy. Also the other symptoms; loss of appetite, nausea/vomiting and diarrhoea increased significantly and were significantly correlated to general fatigue. Global quality of life decreased significantly during treatment compared to baseline. The variation of the level in general fatigue after completed therapy was only explained by the level of general fatigue experienced at baseline. The result can lead to a better understanding of the severity of symptoms experienced by patients with uterine cancer treated with radiotherapy. | lld:pubmed |
| pubmed-article:15847900 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15847900 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15847900 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15847900 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15847900 | pubmed:month | May | lld:pubmed |
| pubmed-article:15847900 | pubmed:issn | 0020-7489 | lld:pubmed |
| pubmed-article:15847900 | pubmed:author | pubmed-author:EkmanTorT | lld:pubmed |
| pubmed-article:15847900 | pubmed:author | pubmed-author:AhlbergKarinK | lld:pubmed |
| pubmed-article:15847900 | pubmed:author | pubmed-author:Gaston-Johans... | lld:pubmed |
| pubmed-article:15847900 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15847900 | pubmed:volume | 42 | lld:pubmed |
| pubmed-article:15847900 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15847900 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15847900 | pubmed:pagination | 377-86 | lld:pubmed |
| pubmed-article:15847900 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15847900 | pubmed:meshHeading | pubmed-meshheading:15847900... | lld:pubmed |
| pubmed-article:15847900 | pubmed:meshHeading | pubmed-meshheading:15847900... | lld:pubmed |
| pubmed-article:15847900 | pubmed:meshHeading | pubmed-meshheading:15847900... | lld:pubmed |
| pubmed-article:15847900 | pubmed:meshHeading | pubmed-meshheading:15847900... | lld:pubmed |
| pubmed-article:15847900 | pubmed:meshHeading | pubmed-meshheading:15847900... | lld:pubmed |
| pubmed-article:15847900 | pubmed:meshHeading | pubmed-meshheading:15847900... | lld:pubmed |
| pubmed-article:15847900 | pubmed:meshHeading | pubmed-meshheading:15847900... | lld:pubmed |
| pubmed-article:15847900 | pubmed:meshHeading | pubmed-meshheading:15847900... | lld:pubmed |
| pubmed-article:15847900 | pubmed:meshHeading | pubmed-meshheading:15847900... | lld:pubmed |
| pubmed-article:15847900 | pubmed:meshHeading | pubmed-meshheading:15847900... | lld:pubmed |
| pubmed-article:15847900 | pubmed:meshHeading | pubmed-meshheading:15847900... | lld:pubmed |
| pubmed-article:15847900 | pubmed:meshHeading | pubmed-meshheading:15847900... | lld:pubmed |
| pubmed-article:15847900 | pubmed:meshHeading | pubmed-meshheading:15847900... | lld:pubmed |
| pubmed-article:15847900 | pubmed:meshHeading | pubmed-meshheading:15847900... | lld:pubmed |
| pubmed-article:15847900 | pubmed:meshHeading | pubmed-meshheading:15847900... | lld:pubmed |
| pubmed-article:15847900 | pubmed:meshHeading | pubmed-meshheading:15847900... | lld:pubmed |
| pubmed-article:15847900 | pubmed:meshHeading | pubmed-meshheading:15847900... | lld:pubmed |
| pubmed-article:15847900 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15847900 | pubmed:articleTitle | The experience of fatigue, other symptoms and global quality of life during radiotherapy for uterine cancer. | lld:pubmed |
| pubmed-article:15847900 | pubmed:affiliation | Department of Oncology, Sahlgrenska University Hospital, SE 413 45 Gothenburg, Sweden. karin.ahlberg@vgregion.se | lld:pubmed |
| pubmed-article:15847900 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15847900 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15847900 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15847900 | lld:pubmed |
